Lipella Pharmaceuticals Inc.
LIPO- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347242
No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Lipella Pharmaceuticals Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- +3 vs. Q3 2023
- Shares held
- 370.0K
- +330.4K (+833.4%) vs. Q3 2023
- Total value
- $377.4K
- +$317.9K (+534.7%) vs. Q3 2023
- New holders
- 3
- 3 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIPO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 3 | $7.13K |
| Q4 2024 | 3 | $41.4K |
| Q3 2024 | 5 | $39.7K |
| Q2 2024 | 7 | $284.0K |
| Q1 2024 | 9 | $260.1K |
| Q4 2023 | 7 | $377.4K |
| Q3 2023 | 4 | $59.5K |
| Q2 2023 | 4 | $82.5K |
| Q1 2023 | 6 | $103.6K |
| Q4 2022 | 2 | $44.7K |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Lipella Pharmaceuticals Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 269,829 | $275.2K | 2.43% | +269,829 | New |
| Geode Capital Management, LLC | 42,090 | $42.9K | 0.00% | +42,090 | New |
| Vanguard Group Inc | 34,520 | $35.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 15,865 | $16.2K | 0.00% | +15,865 | New |
| Tower Research Capital LLC (TRC) | 6,919 | $7.06K | 0.00% | +1,999+40.6% | Added |
| UBS Group AG | 761 | $776 | 0.00% | +589+342.4% | Added |
| Wells Fargo & Company | 29 | $30 | 0.00% | +1+3.6% | Added |